Tokyo Tape
Sign in
← Medical Ikkou Group

Quarterly report · Q2

3353.TEDINET S100PCTW
Period2022-03-01 → 2022-08-31
Filed2022-10-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥17.0bn2022-03-01 → 2022-08-31Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales (5-year summary)
Revenue¥16.8bn2021-03-01 → 2021-08-31Cons.Net sales
Operating income¥466m2022-03-01 → 2022-08-31Cons.Operating income
Operating income¥645m2021-03-01 → 2021-08-31Cons.Operating income
Ordinary income¥598m2022-03-01 → 2022-08-31Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income loss (5-year summary)
Ordinary income¥682m2021-03-01 → 2021-08-31Cons.Ordinary income
Profit before tax¥624m2022-03-01 → 2022-08-31Cons.Income before income taxes
Profit before tax¥781m2021-03-01 → 2021-08-31Cons.Income before income taxes
Net income (owners)¥374m2022-03-01 → 2022-08-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥444m2021-03-01 → 2021-08-31Cons.Profit loss attributable to owners of parent
Net income¥386m2022-03-01 → 2022-08-31Cons.Profit loss
Net income¥452m2021-03-01 → 2021-08-31Cons.Profit loss
Total assets¥28.3bnat 2022-08-31Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥30.2bnat 2021-08-31Cons.Total assets (5-year summary)
Total liabilities¥16.1bnat 2022-08-31Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.2bnat 2022-08-31Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥11.6bnat 2021-08-31Cons.Net assets (5-year summary)
Cash and deposits¥7.0bnat 2022-08-31Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
Cash & equivalents¥6.8bnat 2022-08-31Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥8.4bnat 2021-08-31Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2021-02-28dCons.Cash and cash equivalents
Operating cash flow¥496m2022-03-01 → 2022-08-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-03-01 → 2022-02-28Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥334m2021-03-01 → 2021-08-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥291m2022-03-01 → 2022-08-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-03-01 → 2022-02-28Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥47m2021-03-01 → 2021-08-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.2bn2022-03-01 → 2022-08-31Cons.Net cash provided by used in financing activities
Financing cash flow¥65m2021-03-01 → 2022-02-28Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.3bn2021-03-01 → 2021-08-31Cons.Net cash provided by used in financing activities
EPS (basic)¥99.652022-03-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥44.262022-06-01 → 2022-08-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.222021-03-01 → 2021-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.132021-06-01 → 2021-08-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio41.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio36.6%at 2021-08-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2022-08-31−¥497m
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2022-08-31−¥385m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2022-08-31¥11.6bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2022-08-31¥736m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2022-03-01 → 2022-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2022-03-01 → 2022-08-31¥35m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2022-08-31¥1.9bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2022-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥495m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2022-08-31¥20m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2022-03-01 → 2022-08-31¥95m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2022-03-01 → 2022-08-31¥94m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2022-03-01 → 2022-08-31¥876,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2022-03-01 → 2022-08-31¥61m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2022-08-31¥17.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2022-08-31¥17.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2022-08-31¥497m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2022-08-31¥851m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2021-08-31−¥545m
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2021-08-31−¥347m
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2021-08-31¥11.3bn
jpcrp040300-q2r_E03443-000Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2021-08-31¥731m
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue external2021-03-01 → 2021-08-31¥3.9bn
jpcrp040300-q2r_E03443-000Health Carereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥300,000
jpcrp040300-q2r_E03443-000Health Carereportable segmentsegment profit2021-03-01 → 2021-08-31¥146m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2021-08-31¥2.0bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2021-08-31¥1.4bn
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥543m
jpcrp040300-q2r_E03443-000Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2021-08-31¥50m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue2021-03-01 → 2021-08-31¥117m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue external2021-03-01 → 2021-08-31¥116m
jpcrp040300-q2r_E03443-000Real Estatereportable segmentrevenue intersegment2021-03-01 → 2021-08-31¥960,000
jpcrp040300-q2r_E03443-000Real Estatereportable segmentsegment profit2021-03-01 → 2021-08-31¥65m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2021-08-31¥17.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2021-08-31¥16.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2021-08-31¥545m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2021-08-31¥992m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 501
ItemContextValueUnit
Interest expenses noePrior1YTDDuration29758000JPY
Interest expenses noeCurrentYTDDuration26567000JPY
Other noePrior1YTDDuration1701000JPY
Other noeCurrentYTDDuration1769000JPY
Non operating expensesPrior1YTDDuration31460000JPY
Non operating expensesCurrentYTDDuration28336000JPY
Ordinary incomePrior1YTDDuration682450000JPY
Ordinary incomeCurrentYTDDuration598347000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1018000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration20774000JPY
Gain on sales of investment securities eiPrior1YTDDuration104300000JPY
Gain on sales of investment securities eiCurrentYTDDuration6056000JPY
Extraordinary incomePrior1YTDDuration105318000JPY
Extraordinary incomeCurrentYTDDuration26831000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration1109000JPY
Loss on sales of noncurrent assets elCurrentYTDDuration－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration854000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration94000JPY
Loss on sales of investment securities elPrior1YTDDuration－JPY
Loss on sales of investment securities elCurrentYTDDuration618000JPY
Loss on cancellation of leasehold contracts elPrior1YTDDuration4352000JPY
Loss on cancellation of leasehold contracts elCurrentYTDDuration－JPY
Extraordinary lossPrior1YTDDuration6315000JPY
Extraordinary lossCurrentYTDDuration712000JPY
Income before income taxesPrior1YTDDuration781453000JPY
Income before income taxesCurrentYTDDuration624466000JPY
Income taxes currentPrior1YTDDuration324050000JPY
Income taxes currentCurrentYTDDuration209178000JPY
Income taxes deferredPrior1YTDDuration5673000JPY
Income taxes deferredCurrentYTDDuration29193000JPY
Income taxesPrior1YTDDuration329723000JPY
Income taxesCurrentYTDDuration238371000JPY
Profit lossPrior1YTDDuration451729000JPY
Profit lossCurrentYTDDuration386094000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration7673000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration11753000JPY
Profit loss attributable to owners of parentPrior1YTDDuration444056000JPY
Profit loss attributable to owners of parentCurrentYTDDuration374340000JPY
Profit lossPrior1YTDDuration451729000JPY
Profit lossCurrentYTDDuration386094000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-28839000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-34493000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-1223000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration647000JPY
Other comprehensive incomePrior1YTDDuration-30062000JPY
Other comprehensive incomeCurrentYTDDuration-33845000JPY
Comprehensive incomePrior1YTDDuration421666000JPY
Comprehensive incomeCurrentYTDDuration352248000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration413946000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration340467000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2022-08-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2021-08-31pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2022-08-31pass
statement vs summary · operating cash flowconsolidated 2021-03-01/2021-08-31pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2022-08-31pass
statement vs summary · revenueconsolidated 2021-03-01/2021-08-31pass
statement vs summary · revenueconsolidated 2022-03-01/2022-08-31pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2022-08-31pass